Please see profiles on each of the Directors below:
Sir Martin Smith (Chairman)
Member of the Nominations and Management Engagement and Remuneration Committees
Sir Martin Smith joined the Board on 2007. He has been involved in the financial services sector for more than 30 years. He was a founder and senior partner of Phoenix Securities, becoming Chairman of European Investment Banking for Donaldson, Lufkin & Jenrette (DLJ) following the acquisition of Phoenix by DLJ. He was subsequently a founder of New Star Asset Management Ltd. and has a number of other directorships and business interests, including being Chairman of GP Bullhound, and a directorship with Oxford Capital Partners.
His pro-bono interests include serving as Chairman of the Orchestra of the Age of Enlightenment and serving on the boards of a number of other arts organisations including the Royal Academy of Music, the Glyndebourne Arts Trust and the Science Museum Foundation. He has chaired the English National Opera and is a Governor of the Ditchley Foundation.
Member of the Audit Committee and the Nominations and Management Engagement and Remuneration Committees
Sarah Bates joined the Board in 2013. She is currently Chairman of JPMorgan American Investment Trust plc, Witan Pacific Investment Trust plc and St James’s Place plc. She is also a non-executive Director of Polar Capital Technology Trust plc. Sarah is a former Chairman of the Association of Investment Companies. She is also a member of the Universities Superannuation Fund Investment Committee and an advisor to the East Riding Pension Fund and has a number of voluntary appointments on charity or pension fund investment committees. She attended Cambridge University and has an MBA from London Business School.
Dr David Holbrook
Senior Independent Director, Chairman of the Nominations Committee and a member of the Management Engagement and Remuneration Committees.
Dr David Holbrook joined the Board in 2007. He is a qualified physician and a Venture Partner at MTI Partners Limited, a leading technology venture capital investor. He attended London and Oxford Universities, and has an MBA from Harvard Business School. He has held senior positions in a number of blue chip biopharmaceutical organisations including GlaxoSmithKline and Roche.
Samuel D. Isaly
Sam Isaly joined the Board at launch in 1995. Sam is Managing Partner of OrbiMed Capital LLC, the Company’s Investment Manager, and has been a worldwide healthcare investment specialist for more than 30 years having worked in New York and Europe with Chase Manhattan, Société Générale, Crédit Suisse and UBS Warburg.
Chairman of the Management Engagement and Remuneration Committee and a member of the Audit and Nominations Committees
Doug McCutcheon joined the Board in 2012. He is the President of Longview Asset Management Ltd. and Gormley Limited, independent investment firms. Until 2012, Doug was an investment banker at S.G. Warburg and then UBS for 25 years, most recently as the head of Healthcare Investment Banking for Europe, the Middle East, Africa and Asia-Pacific. Doug is involved in several philanthropic organisations with a focus on healthcare and education. He attended Queen’s University, Canada.
Humphrey van der Klugt
Chairman of the Audit Committee and a member of the Nominations and Management Engagement and Remuneration Committees.
Humphrey van der Klugt joined the Board in 2016. He is a Director of JPM Claverhouse Investment Trust plc and Allianz Technology Trust PLC. He was formerly Chairman of Fidelity European Values PLC and a Director of Murray Income Trust PLC and BlackRock Commodities Income Investment Trust plc. Prior to this Humphrey was a fund manager and Director of Schroder Investment Management Limited and in a 22 year career was a member of their Group Investment and Asset Allocation Committees. Prior to joining Schroders, he was with Peat Marwick Mitchell & Co (now KPMG) where he qualified as a Chartered Accountant in 1979.
Read about the Anti-bribery and Corruption Policies here.